Impact of pathogenic mutations of the GLUT1 glucose transporter on solute carrier dynamics using ComDYN enhanced sampling [version 2; peer review: 2 approved, 1 approved with reservations]
Background: The solute carrier (SLC) family of membrane proteins is a large class of transporters for many small molecules that are vital for cellular function. Several pathogenic mutations are reported in the glucose transporter subfamily SLC2, causing Glut1-deficiency syndrome (GLUT1DS1, GLUT1DS2)...
Saved in:
| Main Authors: | K. Anton Feenstra, Akiko Higuchi, Kei Yura, Sanne Abeln, Halima Mouhib |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2022-06-01
|
| Series: | F1000Research |
| Subjects: | |
| Online Access: | https://f1000research.com/articles/8-322/v2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diversity, expression, and structural modeling of sugar transporters in Anisakis simplex s. s. L3 and L4 larvae: an in vitro and in silico study
by: Iwona Polak, et al.
Published: (2025-08-01) -
Nuciferine relieves type 2 diabetes mellitus via enhancing GLUT4 expression and translocation
by: Tongxi Zhou, et al.
Published: (2023-11-01) -
Placental expression of GLUT‐1, GLUT‐3, and GLUT‐4 mRNA and transcriptome profiling in pregnant women with diabetes
by: Rafal Sibiak, et al.
Published: (2025-03-01) -
The development of a novel high-throughput membrane potential assay and a solid-supported membrane (SSM)-based electrophysiological assay to study the pharmacological inhibition of GLUT9/SLC2A9 isoforms in a drug discovery program
by: Antje Pommereau, et al.
Published: (2024-12-01) -
The NLRP3 molecule influences the therapeutic effects of mesenchymal stem cells through Glut1-mediated energy metabolic reprogramming
by: Jingrou Chen, et al.
Published: (2024-11-01)